June 5, 2018

June 5, 2018

Rubius Therapeutics Appoints Pablo J. Cagnoni, M.D. as Chief Executive Officer
Read More

OURSCIENCE

Red-Cell Therapeutics products are an innovative new class of medicines which address a wide array of diseases and disorders.

Learn More

OURFOCUS

Rubius® is developing a new class of medicines to address a wide array of indications, with leading applications in cancer, enzyme replacement therapy and tolerance induction.

Learn More

Careers

We are building a company dedicated to dramatically improving the lives of patients living with serious diseases.

Join Our Team